Medical Communications

Showing 15 posts of 6408 posts found.

24327909026_6435de0904_z

Ketamine’s antidepressant effects may be linked to brain’s opioid system

September 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ketamine, antidepressant, depression, mental health, opioid

Ketamine’s antidepressant effect works through the activation of the brains opioid receptors, a new study published in The American Journal …
jackie_fouse_hires

Agios appoints Celgene’s Jacqualyn Fouse as new CEO

September 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, COO, Celgene, Jacqualyn Fouse, agios

The Massachusetts-based oncology specialist Agios Pharmaceuticals has appointed former Celgene President and COO Jacqualyn Fouse as their new Chief Executive …
shutterstock_206748499

FDA turns to real-world evidence to improve regulatory process

September 5, 2018 Medical Communications, Research and Development, Sales and Marketing FDA, pharma, real world data, real world evidence, real-world data, real-world evidence

The FDA has announced its intention to incorporate real-world data elements to a greater degree into its regulatory decision-making framework …
melanie_lee_770x510

UK research charity LifeArc appoints experienced leader Melanie Lee as new CEO

September 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, melanie lee

The life sciences medical research charity LifeArc, formerly MRC Technology, has appointed Dr Melanie Lee as its new Chief Executive …
dia_logo

DIA Value, Access, and Regulatory Conference 2018

September 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dia, event, pharma

Dr Solange Corriol-Rohou, Senior Director, Global Regulatory Affairs & Policy, Europe, at AstraZeneca Global Medicines Development, discusses DIA’s upcoming Value, …

Faubel-Booklet Labels

September 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Faubel-Booklet Labels with temperature indicators from ELPRO identify and monitor pharmaceutical products Melsungen, 3rd of September 2018Pharmaceutical products without proper …
shutterstock_192094955_web

Widening the focus on innovations in cancer treatment

September 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, CRUK, Cancer, GSK, diagnosis, genetics, oncology, pharma

Cancer treatment is making leaps and bounds, but public focus tends to gravitate towards the therapies themselves. Matt Fellows explores …
pharmafocus_oct_2018

The September 2018 issue of Pharmafocus is available to read online now!

September 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, AstraZeneca, Cancer, Iraw, J&J, JJ, Pfizer, Roche, UK, brexit, drug safety, pharma, pharmacovigilance

The new September edition of Pharmafocus is now live and available to read online. We’re entering the final stretch as …

DIA’s Global Clinical Trials Transparency Conference & Clinical Trials Regulations Conference

August 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Disclosure and transparency of clinical trial information is taking on new dimensions in the EU and US. Moreover, while the …
479370088_2e7091fc6e_z

Global orphan and rare dermatology market set to exceed $6 billion by 2024

August 31, 2018 Medical Communications Orphan Drugs, analysis, dermatology, market reports, rare diseases

The global orphan and rare dermatology premium products market is expected to grow rapidly in the next half a decade …
shire_image

Shire hands over its oncology franchise to Servier for $2.4bn

August 31, 2018 Medical Communications, Sales and Marketing Cancer, Servier, Shire, oncology, pharma, sale

Shire has completed the sale of its oncology franchise to French firm Servier for $2.4 billion, handing over the global …
donald_trump_29496131773

Trump administration resists WHO efforts to tackle antimicrobial resistance

August 31, 2018 Medical Communications AMR, Trump, US, US government, WHO, antimicrobial resistance

The Trump administration is in the process of drafting an alternative to the World Health Organization’s guidelines on the use …
astrazeneca-sign

AZ’s lupus drug fails to curb lupus activity at Phase 3

August 31, 2018 Medical Communications, Research and Development AstraZeneca, Lupus, anifrolumab, pharma

AstraZeneca and its biologics R&D arm MedImmune have released a statement admitting that their fully human monoclonal antibody anifrolumab failed …
The Gateway to Local Adoption Series

Latest content